Recent Press Releases

Specialty Vaccine Company PaxVax, Inc. Appoints Nima Farzan As President

PaxVax, Inc., a specialty vaccine company focused on travel and biodefense, today announced the appointment of Nima Farzan as President and Chief Operating Officer (COO). Mr. Farzan, who has served...

Myriad Genetics Names Johnathan M. Lancaster as Vice President of Medical Affairs

Former President of Moffitt Medical Group Joins Oncology Leadership Team SALT LAKE CITY, Utah, Jan. 22, 2015 – Myriad Genetics, Inc. (NASDAQ: MYGN) today announced that Johnathan M. Lancaster,...

Halozyme Therapeutics, Inc. (HALO) Appoints Jean-Pierre Bizzari, M.D. To Board Of Directors

SAN DIEGO, Jan. 21, 2015 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced the appointment of Jean-Pierre Bizzari, M.D. to its Board of Directors. Dr. Bizzari brings...

Seres Health Announces Addition Of Mark Wilcox, M.D. To Scientific Advisory Board

CAMBRIDGE, Mass., Jan. 21, 2015 /PRNewswire/ -- Seres Health, Inc., a leading microbiome therapeutics platform company developing a novel class of biological drugs that are designed to treat diseases...

Robert J. Spiegel, M.D., FACP Joins Sucampo Pharmaceuticals, Inc. (SCMP)'s Board Of Directors

BETHESDA, Md., Jan. 21, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that Robert J. Spiegel, M.D., FACP has...

GPhA President And CEO Ralph G. Neas To Step Down In The Fall Of 2015

WASHINGTON, Jan. 20, 2015 /PRNewswire-USNewswire/ -- The Generic Pharmaceutical Association (GPhA) announced today that Ralph G. Neas, President and CEO, would be stepping down from his position in...

Repligen Corporation (RGEN) Names Tony Hunt As Next Chief Executive Officer

WALTHAM, Mass., Jan. 21, 2015 (GLOBE NEWSWIRE) -- Repligen Corporation (Nasdaq:RGEN) announced today that its Board of Directors has appointed Tony J. Hunt to be the Company's next Chief...

Repligen Corporation (RGEN) Names Tony Hunt As Next Chief Executive Officer

WALTHAM, Mass., Jan. 21, 2015 (GLOBE NEWSWIRE) -- Repligen Corporation (Nasdaq:RGEN) announced today that its Board of Directors has appointed Tony J. Hunt to be the Company's next Chief...

Bristol-Myers Squibb Company (BMY) Names Caforio As New CEO Effective May 5

Bristol-Myers Squibb (BMY) grabbed headlines late Tuesday when it announced it had named former chief operating officer Giovanni Caforio as the company's new CEO, effective May 5, to replace...

GenoSpace Expands Board With Appointment Of Michelle Munson

CAMBRIDGE, Mass., Jan. 22, 2015 /PRNewswire/ -- GenoSpace, a precision medicine software company that has developed a comprehensive suite of tools to enable the broad use of genomic, imaging and...

BioInvent (BOVNF) Appoints Head Of Clinical Development

BioInvent International AB (STO:BINV) today announced that Anna Wickenberg has been appointed as Vice President Clinical Development, responsible for the clinical development of BioInvent's drug...

Ariad Pharmaceuticals, Inc. (ARIA) Announces Appointment Of Thomas J. DesRosier, Senior Pharmaceutical-Industry Counsel, As Chief Legal And Administrative Officer

ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced the appointment of Thomas J. DesRosier, Esq. to the position of executive vice president, chief legal and administration officer, and...

Seward Appoints Dan Crothers As Managing Director

Worthing, UK – 19th January 2015 – Seward Ltd., manufacturer of the world leading range of original Stomacher® paddle blenders and accessories used in sample preparation for...

Cipher Pharmaceuticals (DND.TO) Appoints Lynne Bulger As Vice President, Medical Affairs

Company also announces promotions of Peter Weiler and Linda Angaritis MISSISSAUGA, ON, Jan. 19, 2015 /PRNewswire/ - Cipher Pharmaceuticals Inc. (NASDAQ:CPHR; TSX:CPH) ("Cipher" or "the...

Nutra Pharma Corp. (NPHC) Announces Addition Of Keith Gordon, DVM To The Company's Medical Advisory Board

CORAL SPRINGS, FL--(Marketwired - January 20, 2015) - Nutra Pharma Corporation (OTC: NPHC), a biotechnology company that is developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency...

BIO Announces Jamie Gregorian to Join as Director, Federal Government Relations

WASHINGTON--(BUSINESS WIRE)--Today, the Biotechnology Industry Organization (BIO) announces that Jamie Gregorian will be joining staff as Director, Federal Government Relations. "Jamie's experience...

Certara Appoints Gavin Nichols as President of Technology and Head of its Software Business Unit

Nichols brings more than 25 years of technology leadership in clinical informatics and advanced analytics to the company PRINCETON, N.J.--(BUSINESS WIRE)--Certara®, the global biosimulation...

MIT Holding Inc. (MITD) Names Tommy J. Duncan As President

LOS ANGELES, CA--(Marketwired - January 20, 2015) - MIT Holding, Inc. (OTCQB: MITD) today announces Tommy J. Duncan as president of day-to-day operations at MIT Holding. This appointment coincides...

DNASTAR Appoints Tom Lynch Vice President Of Sales

MADISON, Wisconsin – January 20, 2015 – DNASTAR announced today that Dr. Thomas Lynch will return to the company as Vice President of Sales. Dr. Lynch was a member of DNASTAR's team of...

Dr. Murad A. Sunalp, Internationally Recognized Ophthalmology Expert, Joins AXIM Biotechnologies Advisory Board

NEW YORK, Jan. 20, 2015 (GLOBE NEWSWIRE) -- AXIM Biotechnologies (OTC:AXIM) is actively recruiting top minds and experts in medicine. The Company is pleased to announce that Murad A. Sunalp M.D.,...